Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Talbot issue is 100% phony
Too many variables. If you go by the only factual information to date, which is the 1 billion dollar number 'declared' by Leckrone and communicated to PTSC, then over 300 million has been received. That leaves ~700 million left. Split that and include expenses of say 15%, which is a calculation by another poster and one I believe is realitively credible, you now have ~300 million. Apply taxes against 300 million and now you are at ~200 million. Let's put in a conservative estimate and cut 200 million in half and say 100 million is left. Still, if TPL and PTSC can coordinate some PRS with dividends, the SP could pop. A far cry from billions.
Share
New Message
Please login to post a reply